| Analysis | Metabolite Name | Measured Value | Units | AGE | Assay | DISEASE_STATE | Timepoint |
|---|---|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 493907 | Peak area normalized | 17 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 498960 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 502785 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 524780 | Peak area normalized | 14 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 540646 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 552608 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 556078 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 557432 | Peak area normalized | 12 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 563888 | Peak area normalized | 14 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 567451 | Peak area normalized | 13 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 573080 | Peak area normalized | 13 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 593754 | Peak area normalized | 13 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 602497 | Peak area normalized | 12 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 632890 | Peak area normalized | 16 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 658653 | Peak area normalized | 12 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 673405 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 690404 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 695761 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 749140 | Peak area normalized | 16 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 750766 | Peak area normalized | 16 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 768768 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 822753 | Peak area normalized | 12 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 859469 | Peak area normalized | 15 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 864147 | Peak area normalized | 12 | BC TP | PCOS | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 895387 | Peak area normalized | 15 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1024833 | Peak area normalized | 17 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1055577 | Peak area normalized | 13 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1102424 | Peak area normalized | 14 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1132595 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1180996 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1220620 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1278236 | Peak area normalized | 12 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1280120 | Peak area normalized | 13 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1491661 | Peak area normalized | 12 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1494448 | Peak area normalized | 12 | BC TP | Control | 270 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1541679 | Peak area normalized | 15 | OGTT | PCOS | 90 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1542134 | Peak area normalized | 14 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1648277 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1702342 | Peak area normalized | 13 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1740457 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1769529 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1843859 | Peak area normalized | 17 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1883456 | Peak area normalized | 13 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1891162 | Peak area normalized | 16 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1945820 | Peak area normalized | 13 | OGTT | Control | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1954559 | Peak area normalized | 16 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 1957022 | Peak area normalized | 13 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2032525 | Peak area normalized | 12 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2071260 | Peak area normalized | 12 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2072887 | Peak area normalized | 16 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2125120 | Peak area normalized | 15 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2162458 | Peak area normalized | 12 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2173749 | Peak area normalized | 12 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2189748 | Peak area normalized | 16 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2270020 | Peak area normalized | 16 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2281076 | Peak area normalized | 14 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2288500 | Peak area normalized | 12 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2316072 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2387538 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2496942 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2560577 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2665524 | Peak area normalized | 12 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2675985 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2768643 | Peak area normalized | 13 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2837712 | Peak area normalized | 17 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2880748 | Peak area normalized | 14 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 2942989 | Peak area normalized | 16 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3042388 | Peak area normalized | 16 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3160102 | Peak area normalized | 12 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3163717 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3339386 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3436440 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3548134 | Peak area normalized | 12 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3660515 | Peak area normalized | 13 | OGTT | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3723173 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 3913874 | Peak area normalized | 12 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 4052220 | Peak area normalized | 15 | OGTT | PCOS | 30 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 4077412 | Peak area normalized | 15 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 4087136 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 4325348 | Peak area normalized | 12 | BC TP | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 4608419 | Peak area normalized | 16 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 5104646 | Peak area normalized | 13 | BC TP | Control | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 5238624 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 5255394 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 5424659 | Peak area normalized | 15 | OGTT | PCOS | 120 |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 6295449 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 6407003 | Peak area normalized | 16 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 8231305 | Peak area normalized | 15 | OGTT | PCOS | - |
| Reversed phase NEGATIVE ION MODE | ARACHIDONIC ACID (M-H)- | 8305168 | Peak area normalized | 12 | OGTT | PCOS | - |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|